IBDEI0VN ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15374,1,5,0)
 ;;=5^Periumbilical Tenderness
 ;;^UTILITY(U,$J,358.3,15374,2)
 ;;=^303347
 ;;^UTILITY(U,$J,358.3,15375,0)
 ;;=789.66^^81^943^30
 ;;^UTILITY(U,$J,358.3,15375,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15375,1,4,0)
 ;;=4^789.66
 ;;^UTILITY(U,$J,358.3,15375,1,5,0)
 ;;=5^Epigastric Tenderness
 ;;^UTILITY(U,$J,358.3,15375,2)
 ;;=^303348
 ;;^UTILITY(U,$J,358.3,15376,0)
 ;;=070.1^^81^943^50
 ;;^UTILITY(U,$J,358.3,15376,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15376,1,4,0)
 ;;=4^070.1
 ;;^UTILITY(U,$J,358.3,15376,1,5,0)
 ;;=5^Hepatitis A
 ;;^UTILITY(U,$J,358.3,15376,2)
 ;;=^126486
 ;;^UTILITY(U,$J,358.3,15377,0)
 ;;=070.30^^81^943^51
 ;;^UTILITY(U,$J,358.3,15377,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15377,1,4,0)
 ;;=4^070.30
 ;;^UTILITY(U,$J,358.3,15377,1,5,0)
 ;;=5^Hepatitis B, Acute
 ;;^UTILITY(U,$J,358.3,15377,2)
 ;;=^266626
 ;;^UTILITY(U,$J,358.3,15378,0)
 ;;=070.32^^81^943^52
 ;;^UTILITY(U,$J,358.3,15378,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15378,1,4,0)
 ;;=4^070.32
 ;;^UTILITY(U,$J,358.3,15378,1,5,0)
 ;;=5^Hepatitis B, Chronic
 ;;^UTILITY(U,$J,358.3,15378,2)
 ;;=^303249
 ;;^UTILITY(U,$J,358.3,15379,0)
 ;;=070.51^^81^943^53
 ;;^UTILITY(U,$J,358.3,15379,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15379,1,4,0)
 ;;=4^070.51
 ;;^UTILITY(U,$J,358.3,15379,1,5,0)
 ;;=5^Hepatitis C, Acute
 ;;^UTILITY(U,$J,358.3,15379,2)
 ;;=^266632
 ;;^UTILITY(U,$J,358.3,15380,0)
 ;;=070.54^^81^943^54
 ;;^UTILITY(U,$J,358.3,15380,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15380,1,4,0)
 ;;=4^070.54
 ;;^UTILITY(U,$J,358.3,15380,1,5,0)
 ;;=5^Hepatitis C, Chronic
 ;;^UTILITY(U,$J,358.3,15380,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,15381,0)
 ;;=571.41^^81^943^55
 ;;^UTILITY(U,$J,358.3,15381,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15381,1,4,0)
 ;;=4^571.41
 ;;^UTILITY(U,$J,358.3,15381,1,5,0)
 ;;=5^Hepatitis, Chronic Persist
 ;;^UTILITY(U,$J,358.3,15381,2)
 ;;=^259093
 ;;^UTILITY(U,$J,358.3,15382,0)
 ;;=571.1^^81^943^56
 ;;^UTILITY(U,$J,358.3,15382,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15382,1,4,0)
 ;;=4^571.1
 ;;^UTILITY(U,$J,358.3,15382,1,5,0)
 ;;=5^Hepatitis, ETOH Acute
 ;;^UTILITY(U,$J,358.3,15382,2)
 ;;=^2597
 ;;^UTILITY(U,$J,358.3,15383,0)
 ;;=070.59^^81^943^58
 ;;^UTILITY(U,$J,358.3,15383,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15383,1,4,0)
 ;;=4^070.59
 ;;^UTILITY(U,$J,358.3,15383,1,5,0)
 ;;=5^Hepatitis, Other Viral
 ;;^UTILITY(U,$J,358.3,15383,2)
 ;;=^266631
 ;;^UTILITY(U,$J,358.3,15384,0)
 ;;=573.3^^81^943^57
 ;;^UTILITY(U,$J,358.3,15384,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15384,1,4,0)
 ;;=4^573.3
 ;;^UTILITY(U,$J,358.3,15384,1,5,0)
 ;;=5^Hepatitis, Other
 ;;^UTILITY(U,$J,358.3,15384,2)
 ;;=^56268
 ;;^UTILITY(U,$J,358.3,15385,0)
 ;;=555.9^^81^943^13
 ;;^UTILITY(U,$J,358.3,15385,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15385,1,4,0)
 ;;=4^555.9
 ;;^UTILITY(U,$J,358.3,15385,1,5,0)
 ;;=5^Crohn's Disease
 ;;^UTILITY(U,$J,358.3,15385,2)
 ;;=Crohn's Disease^29356
 ;;^UTILITY(U,$J,358.3,15386,0)
 ;;=787.91^^81^943^14
 ;;^UTILITY(U,$J,358.3,15386,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15386,1,4,0)
 ;;=4^787.91
 ;;^UTILITY(U,$J,358.3,15386,1,5,0)
 ;;=5^Diarrhea
 ;;^UTILITY(U,$J,358.3,15386,2)
 ;;=^33921
 ;;^UTILITY(U,$J,358.3,15387,0)
 ;;=562.11^^81^943^15
 ;;^UTILITY(U,$J,358.3,15387,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15387,1,4,0)
 ;;=4^562.11
 ;;^UTILITY(U,$J,358.3,15387,1,5,0)
 ;;=5^Diverticulitis, Colon
 ;;^UTILITY(U,$J,358.3,15387,2)
 ;;=^270274
 ;;^UTILITY(U,$J,358.3,15388,0)
 ;;=562.10^^81^943^16
 ;;^UTILITY(U,$J,358.3,15388,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI0VN
